Top Medical Devices Startups in 2024

The biggest waste in manufacturing today is not on the shop floor. It's in the meetings, emails, and data transfer that overwhelm knowledge processes (eg quality assurance, vendor management, engineering, R&D, and sales). That's because traditional enterprise tools split collaboration and processes into disparate systems, resulting in up to 85% of time and effort being wasted. Unifize solves this problem by bringing collaboration and process into one place. By creating a conversation for every process record, Unifize measurably reduces waste in knowledge processes by up to 95%.

Essenvia is an online platform to streamline regulatory pathway for medical device companies. FDA research data indicates that regulatory submissions have grown in complexity and size with an average of 1185 pages per submission, with a consistent 30% rejected at initial review and 64% sent back for additional information. Essenvia’s regulatory software streamlines the regulatory submission process by improving collaboration and automating some of the most time-consuming and error-prone tasks. Submissions processed on Essenvia reduce time and effort by 40% and eliminate 52% of errors. We are determined to reduce avoidable errors in regulatory submission and help medical device companies accelerate time to market.

Portable spirometer with a mobile interface that objectively tracks asthma severity to allow for a personalized and real-time action plan.

Operating in nine countries, we have established ourselves as one of the global leaders in modern hearing care. In 2015, we opened our doors in the U.S. and made our presence known in the hearing aid industry. Since then, we've helped millions of people improve their quality of life. How did we accomplish this? It’s simple – we put our customers’ needs first.

The first-ever AI-driven wearable ultrasound technology that can be used at pharmacies, and even at homes for providing a connected diagnostics system focusing on critical injuries and diseases. The COVID-19 outbreak has spread its feathers of destruction around the globe with high infected caseloads and many fatalities. People with comorbidities are more prone to contracting COVID-19. Therefore, going to a hospital or clinic for treatment and diagnosis is not recommended for such people. To enable efficient care and quick diagnosis of patients with chronic illnesses, home diagnosis devices are a feasible option. PONS was born out of the necessity to solve a problem that was affecting our everyday life; we wanted to improve the experience of a connected health care system. PONS is focused to harness the integration of machine learning algorithms and rugged, portable ultrasound devices to develop an easy-to-use system that enables emergency responders to quickly assess the severity of a patient’s brain and spine injuries at accidents and in remote environments in which expert medical imaging personnel and advanced imaging equipment are not readily available. Our aim is to facilitate a rapid, precise, and safe pre-hospital diagnostics system, focusing on traumatic brain and spine injuries already on-site, in the ambulance, or at home before transportation to the hospital. PONS social responsibility for affordable health care for everyone stands as our top priority. The system is meant to be used by doctors who serve in difficult circumstances and geographies like 3rd World countries, villages, immigration centers. Doctors without borders, Red Cross, UN, are some of the target groups that we want to reach and provide a smart and affordable diagnostics tool that can be used to track and monitor brain, spine injuries are expensive and big systems can not be used.

MedGEO is a startup in stealth mode on a mission to reimagine health care through the use of innovative technology. Modern hospitals are burdened with archaic legacy systems placing the administrative load on healthcare professionals and as a result, clinicians spend less time caring for patients.

Oncoustics is a unique and innovative player in the medical AI space today. Oncoustics is creating and deploying advanced AI solutions for low cost, non-invasive surveillance, diagnostics, and treatment monitoring of diseases with high unmet clinical need. We apply AI to raw ultrasound signals from readily available handheld ultrasound devices to rapidly differentiate healthy versus diseased tissues. Initially we are targeting liver disease, a $30B global diagnostic market. This year we’re filing our FDA 510(k) for Onc 001 that detects liver fibrosis. Several follow-on liver products are in development. We also have clinical data on other organ indications including prostate, kidney, breast and thyroid diseases and cancers.

Science develops advanced technologies with the goal to, over time, blur the line between medical devices and consumer electronics. Today we are focused on debilitating conditions for which there is a serious unmet medical need. As these technologies mature, they hold the potential to profoundly reshape the human condition.

Neuralink is developing a fully-implanted, wireless, high-channel count brain-machine interface (BMI) with the goal of enabling people with paralysis to directly use their neural activity to operate computers and mobile devices with speed and ease. Neuralink was founded in 2016 by Elon Musk and the company is headquartered in Fremont, CA with a second location opening in Austin, TX.

Eli is a women's health company on a mission to improve lifelong health through continuous hormone monitoring. Hormones impact physical and mental health every day and at every stage of life. Eli offers real-time insights from hormones in saliva that can be tracked continuously over time, unlike traditional testing methods or send-out tests that only provide a single snapshot. With just three simple steps, Eli's at-home technology provides women with personalized hormone profiles to make informed decisions about their health. Eli is filling a data gap to transform how women manage their hormonal health in key areas like menopause, fertility, contraception, and endocrine conditions. Eli has raised a total of $9 million so women can have the information they need to optimize their overall health from puberty to beyond menopause.